2 transcripts
NOTV
Earnings call transcript
NASDAQ
2024 Q3
8 Aug 24
expect biopharma companies in the short term to continue to take a restrained conservative approach to the preclinical pipeline products in order
NOTV
Earnings call transcript
NASDAQ
2023 Q3
10 Aug 23
, that there'll be a significant reduction. We're looking at that and pricing and saying, okay, let's make sure, as I said, let's set a conservative
- Prev
- 1
- Next